J Matthew Singleton's Net Worth

$4.46 Million

Estimate Recalculated Apr 8, 2025 11:06PM EST

Who is J Matthew Singleton

J Matthew Singleton has an estimated net worth of $4.46 Million. This is based on reported shares across multiple companies, which include Viking Therapeutics, Inc., and CUBIST PHARMACEUTICALS INC.

SEC CIK

J Matthew Singleton's CIK is 0001243514

Past Insider Trading and Trends

2012 was J Matthew Singleton's most active year for acquiring shares with 5 total transactions. J Matthew Singleton's most active month to acquire stocks was the month of May. 2024 was J Matthew Singleton's most active year for disposing of shares, totalling 12 transactions. J Matthew Singleton's most active month to dispose stocks was the month of July. 2013 saw J Matthew Singleton paying a total of $493,025.00 for 38,321 shares, this is the most they've acquired in one year. In 2013 J Matthew Singleton cashed out on 56,347 shares for a total of $1,525,755.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Viking Therapeutics, Inc.

Investor
Updated Oct 25, 2024
Form 4
-62.75%
-16.00K
$41.99
-$1.20M
Oct 25, 2024
9.50K
Sale
Oct 25
Form 4
-22.35%
-5.70K
$35.46
-$390.65K
Aug 22, 2024
19.80K
Sale
Aug 21
Form 4
-62.75%
-16.00K
$32.78
-$942.17K
Aug 19, 2024
9.50K
Sale
Aug 19
Form 4
-68.63%
-20.79K
$32.77
-$1.03M
Aug 14, 2024
9.50K
Sale
Aug 14
Form 4
32.00K
Jan 04, 2024
32.00K
Grant
Jan 02
Form 4
22.00K
Jan 04, 2023
22.00K
Grant
Jan 03
Form 4
22.00K
Jan 05, 2022
22.00K
Grant
Jan 03
Form 4
22.00K
Jan 06, 2021
22.00K
Grant
Jan 04
Form 4
22.00K
Jan 03, 2020
22.00K
Grant
Jan 02
Form 4
22.00K
Jan 03, 2019
22.00K
Grant
Jan 02
Form 4
9.50K
$9.82
$93.26K
May 31, 2018
9.50K
Purchase
May 31
Form 4
16.00K
Jan 03, 2018
16.00K
Grant
Jan 02
Form 4
16.00K
Jan 05, 2017
16.00K
Grant
Jan 03
Form 4
16.00K
Jan 06, 2016
16.00K
Grant
Jan 04
Form 4
20.79K
Apr 30, 2015
20.79K
Grant
Apr 28
Form 3
Apr 28, 2015
Showing 16 results

CUBIST PHARMACEUTICALS INC

Investor
Updated Jun 14, 2013
Form 4
9.47K
Jun 14, 2013
9.47K
Grant
Jun 12
Form 4
Jun 11, 2013
4.97K
Options
Jun 06
Form 4
-88.35%
-27.50K
$36.71
-$1.03M
May 22, 2013
3.63K
Sale
May 22
Form 4
-40.82%
-2.50K
$27.81
-$88.57K
Aug 27, 2012
3.63K
Sale
Aug 24
Form 4
10.71K
Jun 11, 2012
10.71K
Grant
Jun 06
Form 4
-62.02%
-10.00K
$43.06
-$430.56K
Mar 12, 2012
6.13K
Sale
Mar 09
Form 4
-35.56%
-2.00K
$27.09
-$60.78K
Feb 06, 2012
3.63K
Sale
Feb 03
Form 4
329.83%
10.05K
Jun 06, 2011
13.10K
Grant
Jun 02
Form 4
878.30%
17.57K
Jun 14, 2010
19.57K
Grant
Jun 10
Form 4
19.00K
Jun 08, 2009
19.00K
Grant
Jun 04
Form 4
-33.33%
-2.00K
$17.33
-$21.74K
Jan 15, 2009
4.00K
Sale
Jan 14
Form 4
-25.00%
-2.00K
$17.77
-$23.54K
Dec 18, 2008
6.00K
Sale
Dec 17
Form 4
-20.00%
-2.00K
$17.34
-$21.78K
Nov 20, 2008
8.00K
Sale
Nov 19
Form 4
-16.67%
-2.00K
$14.32
-$43.20K
Oct 30, 2008
10.00K
Sale
Oct 29
Form 4
15.00K
Jun 12, 2008
15.00K
Grant
Jun 11
Form 4
15.00K
Jun 08, 2007
15.00K
Grant
Jun 07
Form 4
17.50K
Jun 09, 2006
17.50K
Grant
Jun 08
Form 4
10.00K
Jun 09, 2005
32.50K
Grant
Jun 08
Form 4
12.50K
Jun 14, 2004
12.50K
Grant
Jun 10
Form 4
2.00K
$10.13
$20.26K
May 10, 2004
2.00K
Purchase
May 10
Showing 20 results